SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-055237
Filing Date
2023-03-01
Accepted
2023-03-01 08:30:34
Documents
12
Period of Report
2023-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K d476579d8k.htm   iXBRL 8-K 24203
  Complete submission text file 0001193125-23-055237.txt   144995

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA obsv-20230228.xsd EX-101.SCH 2846
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE obsv-20230228_lab.xml EX-101.LAB 17925
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE obsv-20230228_pre.xml EX-101.PRE 11234
6 EXTRACTED XBRL INSTANCE DOCUMENT d476579d8k_htm.xml XML 3394
Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Filer) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37993 | Film No.: 23689897
SIC: 2834 Pharmaceutical Preparations